Isosorbide mononitrate gel - Biolab

Drug Profile

Isosorbide mononitrate gel - Biolab

Latest Information Update: 24 Jul 2017

Price : $50

At a glance

  • Originator Biolab Industrias Farmaceuticas
  • Class Heart failure therapies; Ischaemic heart disorder therapies; Organic nitrates; Small molecules; Sugar alcohols; Vasodilators
  • Mechanism of Action Nitric oxide donors; Nitric oxide stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Fissure in ano

Most Recent Events

  • 13 Jul 2017 Biolab Sanus withdraws a phase-I trial for Fissure in ano in Brazil prior to enrolment as this study has been cancelled and it has not been initiated (NCT02667535)
  • 16 Feb 2016 Preclinical trials in Fissure in ano in Brazil (Topical) before February 2016
  • 16 Feb 2016 Biolab Sanus plans a phase-I trial for Fissure in ano in Brazil (NCT02667535)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top